Clinical factor for clinicians to choose treatments to refractory ulcerative colitis patients, and the validity of the treatment.

Clinical factor for clinicians to choose treatments to refractory ulcerative colitis patients, and the validity of the treatment. - Clinical factor to choose treatments to refractory ulcerative colitis patients, and the validity of it.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025277

Enrollment

200

Registered

2016-12-15

Start date

2016-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ulcerative colitis patient with steroid-dependent or steroid-resistant

Exclusion criteria

Exclusion criteria: 1.Patients who became observation impossible within 52 weeks after treatment starting 2. Patients whose treatment deviate from health insurance 3. The patient who are judged unsuitable by the researcher.

Design outcomes

Primary

Measure	Time frame
Patient's clinical factors which influences choice of their treatments efficacy ratio and non-recurrence rate of each treatment	—

Countries

Japan

Contacts

Public ContactFuminao Takeshima

Nagasaki university graduate school of Biomedecal Science Department of Gastroenterology and hepatology

ftake@nagasaki-u.ac.jp095-819-7481

Outcome results